UNKNOWN VLOC PRODUCT
Report
- Report Number
- 1219930-2025-03664
- Event Type
- Injury
- Date Received
- August 22, 2025
- Date of Event
- May 23, 2025
- Report Date
- August 22, 2025
- Manufacturer
- COVIDIEN SURGICAL
- Product Code
- GAM
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
TRIANTAFYLLOU, A.; MELA, E.; THEODOROPOULOS, C.; THEODOROU, A.P.; KITSOU, E.; SALIARIS, K.; KATSILA, S.; KAKOUNIS, K.; TRIANTAFYLLOU, T.; THEODOROU, D. ADDRESSING ANASTOMOTIC LEAK AFTER ESOPHAGECTOMY: INSIGHTS FROM A SPECIALIZED UNIT. J. CLIN. MED. 2025, 14, 3694. HTTPS://DOI.ORG/10.3390/ JCM14113694. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
ACCORDING TO THE LITERATURE, A RETROSPECTIVE STUDY EVALUATED THE MANAGEMENT OF ANASTOMOTIC LEAK IN PATIENTS WHO UNDERWENT ESOPHAGECTOMY BETWEEN MARCH 2019 AND MARCH 2025. A BARBED SUTURE WAS USED TO HAND-SEW THE DEFECT FOLLOWING A STAPLED INTRATHORACIC ANASTOMOSIS UNTIL 2023. BETWEEN 2023 AND 2025, THE BARBED SUTURE WAS USED TO PERFORM TOTALLY HAND-SEWN, TWO-LAYER, END-TO-SIDE INTRATHORACIC ANASTOMOSIS. BEGINNING IN 2025, A COMPETITOR SUTURE WAS USED TO PERFORM THE INTRATHORACIC ANASTOMOSIS. A COMPETITOR SUTURE WAS USED TO PERFORM THE CERVICAL ANASTOMOSIS. THERE WERE 241 ESOPHAGEAL RESECTIONS PERFORMED WITH INTRATHORACIC ANASTOMOTIC LEAK OCCURRING IN 14 PATIENTS. DIAGNOSIS WAS CONFIRMED WITH COMPUTED TOMOGRAPHY SCAN OR ENDOSCOPY. TREATMENT INCLUDED INTRAVENOUS ANTIBIOTIC THERAPY, ENDOSCOPIC STENT PLACEMENT, DRAINAGE UNDER RADIOLOGIC GUIDANCE, ENDOSCOPIC VACUUM THERAPY, AND REOPERATION. ONE PATIENT DEVELOPED A TRACHEOESOPHAGEAL FISTULA FOLLOWING ENDOSCOPIC STENT PLACEMENT. PROLONGED HOSPITAL STAY AND READMISSIONS WERE REPORTED, INCLUDING ONE INTENSIVE CARE UNIT (ICU) READMISSION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 189866 | UNKNOWN VLOC PRODUCT | SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC | GAM | COVIDIEN SURGICAL | UNKNOWN VLOC PRODUCT |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other| R| H |